The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer?

BackgroundCardiac resynchronization therapy (CRT) is an established treatment in selected patients suffering from heart failure with reduced ejection fraction (HFrEF). It has been proposed that myocardial fibrosis and inflammation could influence CRT “response” and outcome. Our study investigated th...

Full description

Bibliographic Details
Main Authors: Matteo Beltrami, Alessandro Galluzzo, Riccardo Tappa Brocci, Alessandro Paoletti Perini, Paolo Pieragnoli, Manuel Garofalo, Geza Halasz, Massimo Milli, Maria Barilli, Alberto Palazzuoli
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1180960/full